Artivion (AORT) Net Income towards Common Stockholders (2010 - 2026)
Artivion (AORT) posted Net Income towards Common Stockholders of $1.4 million for Q1 2026, down 41.59% on a QoQ basis from $2.4 million in Q4 2025, and up 380.59% year-over-year from $294843.4 in Q1 2025.
Artivion (AORT) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Artivion's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 380.59% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 154.63% YoY) and the FY2025 annual result came in at $9.8 million, up 173.12% from the prior year.
- Net Income towards Common Stockholders was $1.4 million for Q1 2026 at Artivion, down from $2.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $7.5 million in Q1 2024 and bottomed at -$16.5 million in Q4 2024.
- A 5-year average of -$3.1 million and a median of -$2.3 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders slumped 314.67% — and 2025, when it soared 384.18%.
- Artivion's Net Income towards Common Stockholders stood at $2.2 million in 2022, then slumped by 283.26% to -$4.0 million in 2023, then slumped by 314.67% to -$16.5 million in 2024, then jumped by 114.72% to $2.4 million in 2025, then slumped by 41.59% to $1.4 million in 2026.
- Business Quant data shows AORT's Net Income towards Common Stockholders at $1.4 million in Q1 2026, $2.4 million in Q4 2025, and $6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Artivion | 1.26 Bn | 1.20 Bn | 75.45 Mn | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | -16.48 Mn |
| Sep 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | -13.53 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | -13.71 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -20.10 Mn |
| Sep 30, 2021 | 10.58 Mn |
| Jun 30, 2021 | -2.18 Mn |